Retatrutide is our AL‑M series multi-receptor agonist, designed for researchers mapping complex metabolic signalling. As a single peptide engaging GLP‑1, GIP, and glucagon receptor pathways, it allows precise interrogation of incretin-related networks, dose - response behaviour, and receptor crosstalk in vitro.

We supply Retatrutide in a research-grade format suitable for endocrine modelling, pharmacodynamic profiling, and comparative studies alongside other incretin-mimetic peptides. Consistent batch specifications and verifiable testing (COA available on request) support reproducible experimental design for data-driven teams.

For projects requiring higher total peptide content, we also carry larger Retatrutide vial strengths within the same classification framework, allowing scaling without changing compound identity.

Each vial purchased is supplied with complimentary 3ml Ascend Labs Bacteriostatic Water

Disclaimer: Research use only. Not for human or animal use or consumption.